中粮科技(000930) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥5,212,962,685.30, representing a decrease of 3.66% compared to the same period last year[2] - The net profit attributable to shareholders was -¥51,876,706.89, a significant decline of 2,282.72% year-on-year[2] - The net profit after deducting non-recurring gains and losses was -¥58,761,255.96, down 363.75% from the previous year[2] - The basic earnings per share were -¥0.0279, a decrease of 2,246.15% compared to the same period last year[2] - Total operating revenue for Q3 2024 reached CNY 15,123,940,057.61, an increase of 2.73% compared to CNY 14,721,188,587.73 in Q3 2023[12] - Net profit for Q3 2024 was CNY 21,732,805.28, a significant recovery from a net loss of CNY 345,328,717.95 in the same period last year[13] - Operating costs for Q3 2024 totaled CNY 14,839,035,498.26, up from CNY 14,660,447,483.85 in Q3 2023, reflecting a cost increase of 1.22%[12] - The total comprehensive income for the period attributable to the parent company was CNY 52,304,820.90, a decrease of CNY 338,955,138.07 compared to the previous period[14] Cash Flow and Investments - The net cash flow from operating activities was ¥99,558,655.76, down 92.14% year-on-year[5] - The company reported an investment income of ¥48,753,795.84, a substantial increase of 202.17% compared to the previous year[5] - The company experienced a 30.74% improvement in cash flow from investing activities, totaling -¥233,359,559.52[5] - The financing activities generated a net cash flow of ¥175,066,219.32, a significant increase of 168.79% compared to the same period last year[5] - Cash inflow from operating activities totaled CNY 17,221,535,571.86, compared to CNY 18,029,755,562.06 in the previous period, reflecting a decline[15] - The cash outflow from investing activities was CNY 1,024,573,587.08, an increase from CNY 509,039,726.67 in the previous period[16] - The net cash flow from financing activities was CNY 175,066,219.32, compared to a negative CNY 254,477,525.16 in the previous period, indicating improvement[16] - The cash inflow from investment activities was CNY 791,214,027.56, compared to CNY 172,130,941.64 in the previous period, showing significant growth[16] Assets and Liabilities - The total assets at the end of the reporting period were ¥17,180,087,658.71, an increase of 3.76% from the end of the previous year[2] - The total number of common shareholders at the end of the reporting period was 120,189, with the largest shareholder, COFCO Biochemical Investment Co., Ltd., holding 47.49% of shares[7] - The company's cash and cash equivalents increased to ¥1,667,492,832.99 from ¥1,481,142,071.77, representing a growth of approximately 12.6%[9] - Accounts receivable rose to ¥1,435,457,183.75 from ¥1,006,650,710.08, indicating a significant increase of about 42.5%[9] - Inventory decreased to ¥2,195,872,699.45 from ¥2,534,268,489.13, reflecting a reduction of approximately 13.4%[9] - Total assets increased to CNY 17,180,087,658.71 in Q3 2024, compared to CNY 16,557,861,385.94 in Q3 2023, marking a growth of 3.75%[11] - Total liabilities rose to CNY 6,280,232,155.99, up from CNY 5,704,289,177.42 in the previous year, indicating an increase of 10.09%[11] - The company's equity attributable to shareholders reached CNY 10,509,535,584.81, up from CNY 10,451,611,345.75 in Q3 2023, showing an increase of 0.55%[11] Project Developments - The company is currently facing delays in its 30,000-ton lactide project due to external factors and is planning to optimize the project in response to market changes[8] - The company plans to actively promote the construction of the lactide project despite the current delays[8] - The company is assessing the impact of market changes on its lactide project and plans to make necessary adjustments[8] Other Financial Metrics - The financial expenses for Q3 2024 were CNY 78,435,327.62, compared to CNY 64,460,820.29 in Q3 2023, indicating an increase of 21.66%[13] - The company received CNY 107,456,976.45 in tax refunds, down from CNY 213,223,646.37 in the previous period[15] - The total cash and cash equivalents at the end of the period were CNY 1,555,356,265.89, down from CNY 1,623,240,203.67 in the previous period[16] - The company paid CNY 661,500,974.92 to employees, a decrease from CNY 713,603,577.01 in the previous period[15]